Immunexpress Receives CE Mark and Signs European Commercializa...
SEATTLE and BRISBANE, Australia, March 26, 2020 /PRNewswire-AsiaNet/ -- - SeptiCyte(R) RAPID can swiftly differentiate infection positive (sepsis) from infection negative systemic inflammation in patients suspected of sepsis - Commercialization of SeptiCyte(R) to triage COVID-19 patients will be the focus of Bioca...
Authors: LATEST ASIANET NEWS RELEASES